Background Inappropriate antimicrobial prescribing has been reported in care homes. This may result in serious drugrelated adverse events, Clostridium difficile colonization, and the development of antimicrobial resistance among care home residents. Interventions to improve antibiotic prescribing in nursing homes have been reported through clinical trials, but whether antifungal and antiviral prescribing and residential homes have been considered, or how outcomes were measured and reported in such interventions, remains unclear. Objectives Our aims were to evaluate the effect of interventions to improve antimicrobial stewardship in care homes and to report the outcomes used in these trials. Methods We searched 11 electronic databases and five trial registries for studies published until 30 November 2018. Inclusion criteria for the review were randomized controlled trials, targeting care home residents and healthcare professionals, providing interventions to improve antimicrobial prescribing compared with usual care or other interventions. The Cochrane tools for assessing risk of bias were used for quality assessment. A narrative approach was taken because of heterogeneity across the studies. Results Five studies met the inclusion criteria. The studies varied in terms of types of infection, key targets, delivery of interventions, and reported outcomes. In total, 27 outcomes were reported across the studies, with seven not prespecified in the methods. The interventions had little impact on adherence to guidelines and prevalence of antimicrobial prescribing; they appeared to decrease total antimicrobial consumption but were unlikely to have affected overall hospital admissions and mortality. The overall quality of evidence was low because the risk of bias was high across the studies. Conclusion The interventions had limited effect on improving antimicrobial prescribing but did not appear to cause harm to care home residents. The low quality of evidence and heterogeneity in outcome measurement suggest the need for future well-designed studies and the development of a core outcome set to best evaluate the effectiveness of antimicrobial stewardship in care homes.
Background
The population of older people is growing significantly worldwide. According to a recent United Nations report, the number of people aged ≥ 60 increased substantially by 48% between 2000 and 2015, and this population has been predicted to reach 1.4 billion in 2030 [1] . As part of the response to this change in population dynamics, it is recommended that governments improve long-term care systems, including care homes, to meet the increasing needs of people at advanced age and maintain their well-being [1] .
Care homes or long-term care facilities, comprising nursing homes (providing nursing care) and residential homes (without nursing care), provide services and support for older people, especially those who are very frail or dependent on other care services in their everyday life. The prevalence of antimicrobial prescribing in such facilities varies among countries [2, 3] , and high rates of inappropriate prescribing in terms of dosage, treatment duration, the decision to initiate or withhold antimicrobials, and regimens selected have been reported [4] [5] [6] [7] [8] [9] . Furthermore, residents in care homes tend to receive more antibiotic prescriptions for urinary tract infections (UTIs) than those not in care homes [10] . Inappropriate antimicrobial prescribing may potentially lead to serious drugrelated adverse events and Clostridium difficile infection [11, 12] , with more frequent antibiotic use also linked to the development of resistant pathogens [13] . Antibioticresistant pathogens complicate treatment, reduce quality of life, and increase mortality worldwide [14] . Therefore, approaches to reducing inappropriate antimicrobial prescribing are required to be implemented in long-term care facilities [15] . Antimicrobial stewardship is defined as an intervention to enhance the appropriateness of antimicrobial prescribing to optimize treatment and decrease the likelihood that antimicrobial resistance will develop [16, 17] . Antimicrobial stewardship strategies have been implemented in acute care settings, i.e., hospitals, but there have been calls to extend this to care homes [17] [18] [19] .
A number of interventions, using various approaches to improve antimicrobial prescribing in long-term care facilities, have been undertaken and reported through clinical trials. The overall effect of these interventions has been described in the literature [20, 21] , but these reports do not discuss whether antimicrobial stewardship was implemented in residential homes (as opposed to homes with nursing care) or whether prescribing of other antimicrobials such as antivirals and antifungals was explored. Moreover, how outcomes were measured and reported in antimicrobial stewardship interventions in long-term care facilities remains unclear. Inconsistencies in reported outcomes in general has impeded systematic reviewers in collating and combining findings, and this has been a subject of concern [22] . Furthermore, substantial heterogeneity was reported for 372 outcomes in 47 trials of medication reviews in older patients, with insufficient evaluation of some important outcomes such as adverse events and patient-reported outcomes across the studies [23] . Therefore, the aim of this systematic review was to analyze and evaluate the results of randomized controlled trials (RCTs) of interventions to improve antimicrobial stewardship for older people in care homes. We also sought to identify outcomes used in these trials and how they were reported.
Methods
This systematic review was conducted in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) [24] . The protocol of the review was registered in the International Prospective Register of Systematic Reviews (PROSPERO) registry with the registration code CRD42017070116 [25] .
Eligibility Criteria
All RCTs and cluster RCTs (c-RCTs) were included in this study. Non-English publications were excluded from the review. Participants and settings that were eligible were as follows:
• Residents aged ≥ 65 years living in care homes. We used ≥ 65 years to define "older people" as this is considered the conventional retirement age [1, 26] . We accepted studies where the mean age of care home residents in each study arm was ≥ 65 years.
• Healthcare staff working in care homes or associated with care homes, including care home managers, care assistants, community nurses, general practitioners, and pharmacists responsible for specific care homes. • Care homes. In the UK, care homes include homes providing 24-h care with nurses (nursing homes) or without nurses (residential homes) or both. In the USA, care homes are defined as long-term care facilities that are divided into skilled-nursing facilities and assisted-living facilities. In Australia, care homes are referred to as aged-care facilities providing either high-level or lowlevel care, depending on the needs of residents.
We included any interventions that aimed to enhance antimicrobial stewardship in care homes compared with usual care or other interventions. Interventions were unifaceted or multifaceted (including guideline delivery, training courses, and educational material) to improve antimicrobial prescribing and aimed at healthcare professionals associated with care homes and/or relatives of care home residents. We excluded interventions that focused on cost analysis, medication errors, or infection prevention. Usual care was defined as normal daily care where no attempt was made to deliberately affect antimicrobial prescribing.
Effectiveness of interventions was evaluated by a series of outcomes, decided by the project team after referring to a Cochrane review on interventions to improve antimicrobial prescribing in hospital settings [27] . The primary outcomes of the review were adherence to recommended antimicrobial guidelines, prevalence of antimicrobial prescribing (the proportion of care home residents prescribed antimicrobials), duration of antimicrobial treatment (the number of days that residents received antimicrobial therapy), and total antimicrobial consumption (defined daily doses (DDDs)/1000 resident-days). The secondary outcomes were hospital admissions and mortality. However, we also presented other reported outcomes in included studies that were not related to the review outcomes to provide an overview of the range of outcomes used in antimicrobial stewardship studies. A search strategy was first developed in Ovid MEDLINE in consultation with a subject librarian and was adapted for other databases and trial registries. Search terms are outlined in the search strategies in the electronic supplementary material (ESM) 1. The reference lists of included articles were also searched to identify relevant studies.
Identification of Studies
After removing duplicates, two review authors (HN, and either MT or CH) independently screened all titles and abstracts of retrieved articles to identify potential studies. The authors also independently reviewed the full-text articles and selected eligible studies that met all inclusion criteria. Reasons for exclusion were noted, and disagreement was resolved by discussion.
Risk of Bias
Two review authors (HN, and either MT or CH) independently assessed the methodological quality of included articles using The Cochrane Collaboration's Tool for Assessing Risk of Bias [28] and Risk of Bias Criteria for EPOC Reviews [29] without blinding to authors' names, institutions, and journals of publication. The quality of studies was evaluated using the following criteria: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, similarity of baseline outcomes, similarity of baseline characteristics, contamination protection, and other sources of bias (recruitment after randomization, clustering effect not considered, inappropriate pre-randomization administration of an intervention, "null bias" issues, inappropriate influence of funders, fraud). Any discrepancies of assessment between the authors were resolved by discussion and consultation with a third author.
Data Extraction and Analysis
Two review authors (HN, and either MT or CH) independently performed data extraction from included articles using data extraction sheets, including information on study design (RCT or c-RCT), participants, setting, methods (unit of allocation, unit of analysis, study power, risk-of-bias assessment), type of intervention (components and functions), outcomes, and results. Any discrepancies between the authors were resolved through discussion. Any remaining disagreement or uncertainty was resolved by consensus through discussion with another review author.
The heterogeneity of infections, study designs, and reported outcomes across the included studies meant that meta-analysis was not possible. Therefore, we performed a narrative analysis using the extracted data.
Results
A total of 9045 records were retrieved from 11 electronic databases and five trial registries. After removal of non-English publications and duplicates, 5791 records were included in the abstract screening; 17 articles were fully assessed for eligibility, and five c-RCTs were included in the final analysis. In total, 16 potentially suitable records were identified in the reference lists of the included studies, but none of these abstracts met the eligibility criteria. Figure 1 presents details of the screening and selecting process.
Study Characteristics
The five c-RCTs varied greatly in terms of type of infection, targets for interventions, delivery of interventions, data analysis, and reported outcomes ( Table 1) . The included studies, published between 2001 and 2014, were conducted in Europe and North America: one in the USA [30] , one in both Canada and the USA [31] , one in Canada [32] , one in Sweden [33] , and one in the UK [34] .
The study settings were nursing homes in three studies [31, 33, 34] , skilled-nursing facilities in one study [30] , and long-term care facilities in the remaining trial [32] . None of the five studies recruited residential homes. Two studies focused on all types of infections [32, 34] , whereas two focused on UTIs [31, 33] , and one focused on pneumonia [30] . However, data for all types of infections were also collected and reported briefly in the two studies targeting UTIs [31, 33] . All five studies reported antibiotic-related data; no data relating to antivirals or antifungals were recorded. Study duration ranged from 15 to 20 months. In four studies, the comparator (control group) was usual care [31] [32] [33] [34] , whereas Naughton et al. [30] compared a physician-targeted intervention with a physician-and nursing staff-targeted intervention. With regard to data analysis, the unit of analysis was the care home in two studies [30, 31] , care home residents in two studies [33, 34] , and physicians in the remaining studies [32] .
Characteristics of Interventions
The five included studies targeted different stakeholders to improve antimicrobial prescribing. Three studies developed interventions for both physicians and care home staff [30, 31, 33] , whereas the other two were aimed at physicians only [32] or care home staff only, including home managers [34] . None of the included studies involved care home residents or their family members in development or delivery of the intervention.
Interventions were multifaceted and varied across the studies but shared similar approaches: developing diagnostic and treatment algorithms or guidelines and delivering them to target stakeholders. Naughton and colleagues [30, 35] developed a treatment guideline for nursing home-acquired pneumonia from preceding research and clinical experience, revised it through small group discussions with key physicians and nurse practitioners from general practices who were mainly responsible for recruited care homes, then delivered it to target physicians using laminated cards or to nursing staff in care homes via training sessions. Loeb [33] developed an intervention from available guidelines for UTIs, focus group discussions with local physicians and nursing staff, and their previous work. The intervention was then delivered to target physicians and nurses via training sessions, educational material, and feedback on prescribing. Fleet et al. [34] introduced nursing home staff to an antimicrobial stewardship tool developed from the literature, along with a support pack that substituted for training sessions and regular visits. The support pack included guidance for identifying common infections in older people and collecting specimens, information on antimicrobial resistance, and dedicated study contact information. 
Characteristics of Reported Outcomes
A total of 27 outcomes were identified across the five studies ( Table 2 ). The number of reported outcomes in each study ranged from one to nine. In total, 19 outcomes were documented in the methodology sections of the papers, and 26 outcomes were reported in later sections. One of the 19 prespecified outcomes (severity of pneumonia) was not reported [30] . Seven reported outcomes were not prespecified: two in Loeb et al. [31] , one in Pettersson et al. [33] , and four in Fleet et al. [34] . Additionally, Loeb et al. [31] prespecified an outcome, "admissions to hospital", but reported two related outcomes: rate of all-cause admissions to hospital and rate of admission to hospital for sepsis of suspected urinary origin or of unknown origin. Protocols were identified for two of the five included studies [31, 33] , but only one study reported outcomes that had been prespecified in the protocol [31] .
Effect of Interventions on Outcomes
The marked heterogeneity between studies meant that reported outcomes could not be collated and combined in a quantitative analysis. In total, 16 primary and secondary outcomes reported were related to the five outcomes identified for this systematic review (Table 2) . No study examined the duration of antimicrobial treatment as an outcome.
Adherence to Recommended Antimicrobial Guidelines
Two studies considered adherence to antimicrobial guidelines as the primary outcome [30, 32] . Differences in the comparators between the studies meant the effect of interventions on adherence to guidelines was inconclusive.
Intervention vs. Usual Care
Monette et al. [32] mailed antibiotic guides to physicians on two occasions and found a significant decrease in the proportion of nonadherent antibiotic prescriptions in the intervention group compared with the control group after the second occasion, whereas no significant difference between both groups was identified after the first intervention and during the 3-month follow-up.
Intervention vs. Intervention
Naughton et al. [30] compared two types of interventions: guideline training for physicians with or without assistance of nursing staff in care homes. They found no significant difference between the two groups in prescribing of both parenteral and oral antibiotics compliant with the pneumonia guideline [30] .
Prevalence of Antimicrobial Prescribing

Intervention vs. Usual Care
Three studies reported outcomes related to the prevalence of antimicrobial prescribing in care homes [31, 33, 34] . With regard to total antimicrobial prescribing, no significant difference in the proportion of nursing home residents prescribed antimicrobials between intervention and control groups was identified in two studies [31, 34] . However, Pettersson et al. [33] found a significant decrease in the proportion of all infections treated with antibiotics in the intervention group compared with the control group. In addition, two studies also reported the prevalence of antimicrobial prescribing for particular infections [31, 32] . Loeb et al. [31] found that the rate of antimicrobial use and the proportion of total antimicrobials for suspected UTIs were significantly lower in the intervention group than in the control group, whereas proportions of antimicrobials for respiratory, skin and soft tissue, or other infections were not significantly different between groups. Pettersson et al. [33] also examined antibiotic prescribing for UTIs but found no significant difference in the proportion of quinolones or nitrofurantoin prescribed for women who were followed up in respect of this outcome in nursing homes between both groups.
Total Antimicrobial Consumption
Intervention vs. Usual Care
Two studies reported total antimicrobial consumption by DDDs/1000 residentdays albeit for different infections [31, 34] . Loeb et al. [31] found a significant decrease in the rate of DDDs of prescribed antimicrobials for suspected UTIs in the intervention group compared with the control group. Although there was baseline imbalance in total systemic antibiotic consumption for all types of infections between both groups, Fleet et al. [34] found a significant reduction of DDDs/1000 resident-days in the intervention group in contrast with a significant increase in the control group.
Overall Hospital Admissions
Intervention vs. Usual Care
Two studies reported that no significant difference was identified in hospital admissions, irrespective of cause between the intervention and control groups [31, 33] .
Overall Mortality
Intervention vs. Usual Care
Overall mortality was reported in only one study. Loeb et al. [31] found no significant difference in mortality for all causes between the intervention group and the control group.
Other Outcomes
Intervention vs. Usual Care
Pettersson et al. [33] reported a significant decrease in the proportion of infections managed by physicians as "wait and see" in the intervention group compared with the control group but found no significant difference in the number of UTIs per resident between both groups. Loeb et al. [31] found no significant difference in the rate of urine cultures ordered and in the rate of hospitalization for sepsis between both groups. With regard to appropriateness of prescribing, Fleet et al. [34] found a significant increase in the proportion of residents that fully met published criteria for the initiation of antibiotics in the intervention group compared with the control group. Additionally, the mean point prevalence of antibiotics prescribed for prophylaxis was 2.46% at baseline and 2.18% post-intervention in the intervention group, compared with 4.44% at baseline and 5.10% post-intervention, in the control group. The authors also described compliance of nursing staff with an antimicrobial stewardship tool in the intervention group only and briefly reported no unexpected adverse effects of the tool [34] .
Pre-Intervention vs. Post-Intervention
In the study by Naughton et al. [30] , antibiotic use at the time of diagnosis was compared between the pre-intervention and postintervention groups regardless of the two intervention arms with no apparent significant difference. There was no significant difference in hospitalization rates and in 30-day mortality between before and after interventions [30] .
Quality Assessment
The "risk-of-bias" assessment of the included studies is presented in ESM 2, and the "risk-of-bias" summary across the studies is shown in Figs. 2 and 3 . Overall, blinding of participants and personnel was the highest-rated risk. Moreover, domains that were at high risk of bias in at least two studies included incomplete outcome data, selective reporting, similar baseline characteristics, and similar baseline outcome measurements. At least one element of bias judged as high risk was detected in each study. One study was judged as high risk in the "other bias" domain because the clustering effect had not been considered.
Discussion
This systematic review highlights the effect of interventions and reported outcomes in c-RCTs to improve antimicrobial stewardship in care homes. Although the findings were inconsistent across the studies, the interventions had modest effects on adherence to antimicrobial guidelines and prevalence of antimicrobial prescribing and were likely to improve antimicrobial consumption based on DDDs/1000 resident-days but did not affect overall hospitalization and mortality.
The quality of evidence from the included studies was undermined since several high risks of bias were detected that may have affected the final results. None of the studies were at low risk in terms of blinding of participants and personnel. This is possibly due to the complex nature of the cluster trials, where blinding is difficult to implement. However, this issue can be mitigated by selecting outcomes that are objective and not affected by non-blinded clusters [28] . Baseline balance should be sought in a c-RCT as it increases credibility, analytical power, and statistical precision [36] . Baseline imbalance in the studies potentially compromised final results and possibly downgraded the overall quality of evidence. Moreover, loss to follow-up was the main reason for incompleteness of outcome data, which may have decreased the study power and influenced data interpretation. High risks of bias were also detected in the selective reporting domain. Outcomes that were not reported or reported without being prespecified in the protocols or in the methodology also reduced the credibility and validity of the studies. This issue has been reported in several studies [37] [38] [39] ; Smyth et al. found that the underlying reasons for this feature were related to poor research practice and constrained time for protocol writing [40] .
The findings of the review were consistent with previous publications. An earlier systematic review to determine components of a successful intervention from RCTs on antibiotic prescribing in long-term care facilities found a modest effect from four included studies [20] . Another systematic review to assess the potential benefit of antibiotic stewardship programs in nursing homes indicated an encouraging but limited effect based on findings from 14 studies [21] . Previous systematic reviews focused solely on nursing homes and antibiotic prescribing; we also searched for intervention studies that were conducted in residential homes or that targeted antivirals and antifungals in care homes but found no such studies. High levels of antimicrobial prescribing have also been reported in residential homes, which reinforces the need for antimicrobial stewardship in these facilities [5, 10] . Bacterial infections are the most common infections and have the most significant impact on care home residents [41] , but viral and fungal infections have also been identified among residents of care homes [41] [42] [43] . Research has identified that development of resistance to antivirals and antifungals has occurred in common pathogens [44] [45] [46] . Although prescribing of antivirals and antifungals has been reported in care homes [3, 47] , no study has evaluated their appropriateness. According to the UK National Institute for Health and Care Excellence (NICE), antimicrobial stewardship should focus on not only antibacterials but also antivirals, antifungals, and antiparasitics [17] .
This review detected a total of 27 outcomes across the five studies, which prevented any type of quantitative synthesis. This heterogeneity may be because outcomes were selected according to the characteristics of interventions and target infections, which varied across the studies. It should be noted that none of these outcomes directly assessed antimicrobial resistance. One of the main aims of antimicrobial stewardship is to preserve the future use of antimicrobials or to reduce antimicrobial resistance [16, 17] . However, it is difficult to directly measure antimicrobial resistance, especially in community-based settings, because of the complexity of microbiological methods, variation of antimicrobial-resistant strains, and bias in interpretation [48, 49] . Resistance rates are also possibly manipulated by other factors beyond the scope of antimicrobial stewardship, such as infection-control practices [50] . In addition, it may take several years for trials testing the effectiveness of antimicrobial stewardship programs to result in changes in antimicrobial resistance [49, 51] . Antimicrobial consumption is a good surrogate outcome for antimicrobial resistance, as the relationship between antimicrobial exposure and antimicrobial resistance has been well-established: a decrease in antimicrobial consumption is associated with a decrease in resistance [48, 52] . World Health Organization (WHO)-assigned DDDs have been used widely to calculate antimicrobial consumption in a number of studies because this method has been standardized and its values allow international comparison [53] . However, total antimicrobial consumption expressed in DDDs/1000 residents-days should be interpreted carefully as it may not accurately reflect antimicrobial use. Neilly et al. [54] found an increase in antimicrobial DDDs in contrast to a decrease in the mean number of prescriptions over the study period. In addition, the DDD method inaccurately estimated days of therapy when the actual daily dose was not equal to the DDD, and this method was not recommended in situations where reduced doses were advocated, e.g. renal impairment [55] . Evidence has shown that an increased number of antimicrobial courses is associated with resistance [56] ; therefore, the DDD method is not recommended for use in isolation but could be applied along with the number of antimicrobial courses to best evaluate antimicrobial use.
Besides antimicrobial consumption, other surrogate outcomes, such as duration of treatment and consumption of broad-spectrum antimicrobials, may be closely linked with antimicrobial resistance. Duration of antimicrobial treatment was the primary outcome selected for scrutiny in this review that was not reported in any of the studies. A previous systematic review indicated that the longer the period of antibiotic exposure experienced by a patient in the previous 12 months, the greater the likelihood of isolation of resistant bacteria from that patient in primary care [56] ; in contrast, short duration of antibiotic treatment has been supported by a number of studies to reduce resistance [57] [58] [59] . Duration of treatment, or days of therapy, can be used to measure antimicrobial use regardless of changes in antimicrobial doses [55] . Indeed, the days of therapy approach was one of six recommended metrics to assess antimicrobial stewardship interventions in acute care settings according to an expert consensus [60] . Although duration of antimicrobial treatment may not be measured in some settings because patientlevel data are unavailable [53, 61] , this outcome should be considered in future research focusing on antimicrobial stewardship in care homes. In addition, consumption of broadspectrum antimicrobials has been associated with accelerating antimicrobial resistance and C. difficile colonization [49, 62, 63] . High rates of broad-spectrum antimicrobials prescribed in long-term care facilities have been reported [2, 3] ; therefore, a metric for consumption of broad-spectrum antimicrobials should be considered to assess the impact of antimicrobial stewardship on antimicrobial resistance in care homes.
In addition to the aim of reducing resistance, antimicrobial stewardship should ensure that interventions cause no harm, such as drug-related adverse events, hospitalization, and mortality, or improve clinical outcomes [16, 49] . Although this review found no significant change in rates of hospitalization and mortality, two of the five included studies did not report these outcomes. It should also be noted that hospital admissions and mortality were secondary outcomes in the other two c-RCTs, which had not been powered to detect any difference. Besides clinical outcomes, economic outcomes (e.g., antimicrobial costs) have also been suggested to evaluate the impact of antimicrobial stewardship programs [49, 51] . However, no such outcomes were reported in the included studies in this review.
To date, there is no consensus on what represents the best outcomes and how they are measured to assess the effectiveness of antimicrobial stewardship intervention, especially in care home settings. The number of outcomes reported in this review and the lack of guidelines to best evaluate antimicrobial stewardship in care homes suggests the need to generate a core outcome set for trials aimed at antimicrobial stewardship in these facilities. Since 2010, the Core Outcome Measures in Effectiveness Trials (COMET) initiative has called for the development and application of core outcome sets (COSs) for clinical trials [64] . A COS is defined as a standardized list of outcomes achieved by consensus that should be reported in all trials in a specific health area [65] . It stemmed from the proposal that evidence interpretation would be facilitated and outcome reporting bias would be reduced if all studies focusing on similar issues used the same set of standard outcomes [65] . A COS for antimicrobial stewardship interventions in care homes should have a short list of the most important outcomes that clearly aid in the interpretation of the effectiveness of the interventions.
One of the strengths of this review is the extensive searching in five trial registries, 11 electronic databases, which included two grey literature resources, and all reference lists of the included studies. The search strategy was designed to identify as many potential articles as possible in each database. The review evaluated the effectiveness of c-RCTs, which may provide more reliable evidence than nonrandomized studies. The assessment of methodological quality used nine domains for c-RCTs to rigorously evaluate the included studies. Nevertheless, the review has several limitations. The inclusion of only English publications from the initial records may have led to the exclusion of eligible studies in other languages. The paucity of c-RCTs and the inability to conduct a meta-analysis weakened the quality of the evidence.
Conclusion
This systematic review evaluated the results of interventions from c-RCTs to improve antimicrobial stewardship in care homes. The interventions had a limited effect on improving antimicrobial prescribing and likely caused no harm to care home residents. However, the quality of evidence was low because of the high risk of bias. These findings highlight the need for future well-designed studies aimed at antimicrobial stewardship in care homes that should minimize potential bias, especially blinding of participants, loss to follow-up, and baseline imbalance. Numerous and heterogeneous outcomes that were reported across the studies impeded data synthesis. This reinforces the need for a COS for trials to improve antimicrobial prescribing in care homes to reduce heterogeneity in outcome measurement and to best evaluate the effectiveness of antimicrobial stewardship.
